Bank of America
GHDX

Bank of America’s Genomic Health, Inc. GHDX Stock Holding History

Bank of America’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-11,100
Closed -$292K – 8319
2014
Q1 		$292K Buy
+11,100
New +$318K ﹤0.01% 5098

Bank of America's GHDX Position: Q4 2019 in Review

Bank of America sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 394,312 shares — an estimated $26.7M sold.

Bank of America first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $26.7M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Bank of America reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Bank of America sold 394,312 Genomic Health, Inc. shares in Q4 2019, an estimated $26.7M.
  • Bank of America first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
  • Bank of America's Genomic Health, Inc. position peaked at $26.7M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Bank of America's 13F filing for Q4 2019, filed 14 Feb 2020.